NASDAQ
bioAffinity Technologies, Inc. (BIAF) has a free cash flow growth of -29.37% as of Friday, May 29, 2026. This represents a 125.47% decrease compared to its 12-month average of -13.03%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.